These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 813753)

  • 21. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats.
    Ahlersová E; Ahlers I; Kubatka P; Bojková B; Môciková K; Gajdosová S; Onderková HM
    Folia Biol (Praha); 2000; 46(2):69-72. PubMed ID: 10813093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Welsch CW; Clemens JA; Meites J
    J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
    [No Abstract]   [Full Text] [Related]  

  • 25. Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.
    Tejwani GA; Gudehithlu KP; Hanissian SH; Gienapp IE; Whitacre CC; Malarkey WB
    Carcinogenesis; 1991 Apr; 12(4):637-41. PubMed ID: 1901524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of carcinogen-induced mammary tumor growth in rats by adrenalectomy.
    Chen HJ; Bradley CJ; Meites J
    Cancer Res; 1976 Apr; 36(4):1414-7. PubMed ID: 816463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of transformed nodule and ductal mammary cells from carcinogen-treated C57BL mice.
    Guzman RC; Osborn RC; DeOme KB
    Cancer Res; 1981 May; 41(5):1808-11. PubMed ID: 6783300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis.
    Russo IH; Koszalka M; Russo J
    Br J Cancer; 1991 Sep; 64(3):481-4. PubMed ID: 1911188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of mammary cell division in relation to age: its significance in the induction of mammary tumors by carcinogen in rats.
    Nagasawa H; Yanai R
    J Natl Cancer Inst; 1974 Feb; 52(2):609-10. PubMed ID: 4816015
    [No Abstract]   [Full Text] [Related]  

  • 31. Neonatal modification of endocrine functions and mammary carcinogenesis in the rat.
    Christakos S; Sinha D; Dao TL
    Br J Cancer; 1976 Jul; 34(1):58-63. PubMed ID: 821507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
    VanderPloeg LC; Wolfrom DM; Welsch CW
    Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dietary lipid saturation on prolactin secretion, carcinogen metabolism and mammary carcinogenesis in rats.
    Clinton SK; Mulloy AL; Visek WJ
    J Nutr; 1984 Sep; 114(9):1630-9. PubMed ID: 6432976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of estrogen and-or pituitary graft on nucleic acid synthesis of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Yanai R
    J Natl Cancer Inst; 1974 Apr; 52(4):1219-22. PubMed ID: 4826589
    [No Abstract]   [Full Text] [Related]  

  • 36. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation.
    Swanson SM; Guzman RC; Christov K; Miyamoto S; Nandi S
    Carcinogenesis; 1994 Jul; 15(7):1341-6. PubMed ID: 8033309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas.
    Welsch CW; DeHoog JV
    Cancer Res; 1983 Feb; 43(2):585-91. PubMed ID: 6401220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
    Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
    Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene.
    Drosdowsky M; Edery M; Guggiari M; Montes-Rendon A; Rudali G; Vives C
    Cancer Res; 1980 May; 40(5):1674-9. PubMed ID: 6245799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.